Poster Session 6Assessment of morphology and functionP1222Multimodality imaging for left atrial appendage occluder sizingP1223Longitudinal left atrial strain is a main predictor for long term prognosis on atrial fibrillation after CABG operation patientsP1224Comparison of 2D and 3D left ventricular volumes measurements: results from the SKIPOGH II studyP1225Adjusting for thoracic circumference is superior to body surface area in the assessment of neonatal cardiac dimensions in foetal growth abnormalityP1226Maximal vortex suction pressure: an equivocal marker for optimization of atrio-ventricular delayP1227Volume-time curve of cardiac magnetic resonance assessed left ventricular dysfunction in coronary artery disease patients with type 2 diabetes mellitusP1228Thickness matters, but not in the same way for all strain parametersP1229Digging deeper in postoperative modifications of right ventricular function: impact of pericardial approach and cardioplegiaP1230Left atrial function evaluated by 2D-speckle tracking echocardiography in diabetes mellitus populationP1231The influence of arterial hypertension duration on left ventricular diastolic parameters in patients with well regulated arterial blood pressureP1232Investigation of factors affecting left ventricular diastolic dysfunction determined using mitral annulus velocityP1233High regulatory T-lymphocytes after ST-elevation myocardial infarction relate with adverse left ventricular remodelling assessed by 3D-echocardiographyP1234Prevalence of paradoxical low flow/low gradient severe aortic stenosis measure with 3 dimensional transesophageal echocardiographyP1235Coronary microvascular and diastolic dysfunctions after aortic valve replacement: comparison between mechanical and biological prosthesesP1236Normal-flow, low gradient aortic stenosis is common in a population of patients with severe aortic valve stenosis undergoing aortic valve replacementP1237Analysis of validity and reproducibility of calcium burden visual estimation by echocardiographyP12383D full automatic software in the evaluation of aortic stenosis severity in TAVI patients. Preliminary resultsP1239Differential impact of net atrioventricular compliance on clinical outcomes in patients with mitral stenosis according to cardiac rhythmP1240Aortic regurgitation affects the intima-media thickness of the right and left common carotid artery differentlyP1241Global longitudinal strain: an hallmark of cardiac damage in mitral valve regurgitation. Experience from the european registry of mitral regurgitationP1242Echocardiographic characterisation of Barlow's disease versus fibroelastic deficiencyP1243Echocardiographic screening for rheumatic heart disease in a ugandan orphanage - feasibility and outcomesP1244Alterations in right ventricular mechanics upon follow-up period in patients with persistent ischemic mitral regurgitation after inferoposterior myocardial infarctionP1245Ten-years conventional mitral surgery in patients with mitral regurgitation and left ventricular dysfunction: clinical and echocardiographic outcomes

Autor: B. De Chiara, E. Tamulenaite, M. Mapelli, B. Liu, A. Buonauro, J. Petrini, IJ. Cho, C. Fernandez-Golfin, ML. Panelo, R. Carter-Storch, R. America, R. Henquin, SC. Latet, H. Takase, T. Miljkovic, J. Moreno, C. Loardi, E. Pagourelias, X. Huayan, D. Rodriguez Munoz, RFW Olander, P. Monney, K. Hristova, R. Wassmuth, H. Minden, V. Kostova, N. Nesheva, TZ. Katova, L. Bojadzhiev, V. Crisinel, S. Reverdin, L. Conti, F. Mach, H. Mueller, X. Jeanrenaud, M. Bochud, G. Ehret, JKM Sundholm, T. Ojala, S. Andersson, T. Sarkola, JL. Moya Mur, B. Berlot, J. Moreno Planas, E. Casas Rojo, A. Garcia Martin, JJ. Jimenez Nacher, A. Hernandez-Madrid, E. Franco Diez, R. Matia Frances, JL. Zamorano, YANG Zhigang, GUO Yingkun, CHEN Jing, J. Duchenne, O. Mirea, A. Triantafyllis, B. Michalski, G. Vovas, M. Delforge, J. Van Cleemput, J. Bogaert, JU. Voigt, M. Saccocci, G. Tamborini, F. Veglia, M. Pepi, F. Alamanni, M. Zanobini, JJ. Zuniga Sedano, E. Alexanderson, C. Martinez, M. Bjelobrk, K. Pavlovic, A. Ilic, S. Colakovic, S. Dodic, T. Tanaka, M. Machii, D. Nonaka, PL. Van Herck, MJ. Claeys, SE. Haine, HP. Miljoen, VF. Segers, TR. Vandendriessche, BY. De Winter, VY. Hoymans, CJ. Vrints, M. Lombardero, G. Perea, MM. Miele, DAV De Amicis, VAM Mannacio, JS. Dahl, NL. Christensen, EV. Soendergaard, N. Marcussen, JE. Moeller, C. Fernandez-Palomeque, D. Garcia-Vega, L. Mont-Girbau, A. Pardo, C. Izurieta, I. Boretti, R. Hinojar, A. Gonzalez-Gomez, E. Casas, L. Salido, V. Barrios, S. Ruiz, JL. Moya, R. Hernandez Antolin, JL. Jimenez Nacher, HJ. Chang, HH. Choi, SY. Lee, CY. Shim, JW. Ha, N. Chung, M. Ring, K. Caidahl, MJ. Eriksson, R. Esposito, C. Santoro, JM. Monteagudo, B. Trimarco, M. Galderisi, S. Baig, M. Hayer, R. Steeds, N. Edwards, L. Fusini, P. Zagni, M. Muratori, P. Agostoni, P. Gripari, S. Ghulam Ali, C. Fiorentini, Z. Valuckiene, R. Jurkevicius, A. Peritore, L. Botta, O. Belli, F. Musca, F. Casadei, C. Russo, C. Giannattasio, A. Moreo

Publikováno v: European Heart Journal – Cardiovascular Imaging. 17:ii256.1-ii280

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f8094c5741b6df3966e1a1db0d137599
https://doi.org/10.1093/ehjci/jew266

The continuous heart failure spectrum: moving beyond an ejection fraction classification.

Autor: Triposkiadis F; Department of Cardiology, Larissa University Hospital, Larissa, Greece., Butler J; Department of Medicine-L650, University of Mississippi Medical Center, Jackson, MS, USA., Abboud FM; Abboud Cardiovascular Research Center, University of Iowa, Iowa City, IA, USA., Armstrong PW; Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, Canada., Adamopoulos S; Transplant and Mechanical Circulatory Support Unit, Onassis Cardiac Surgery Center, Athens, Greece., Atherton JJ; Department of Cardiology, Royal Brisbane and Women's Hospital, University of Queensland School of Medicine, Brisbane, Australia., Backs J; Department of Molecular Cardiology and Epigenetics, Heidelberg University, Heidelberg, Germany., Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hannover, Germany., Burkhoff D; Cardiovascular Research Foundation, New York, NY, USA., Bonow RO; Bluhm Cardiovascular Institute, Northwestern University Feinberg School of Medicine, Northwestern Memorial Hospital, Chicago, IL, USA., Chopra VK; Department of Cardiology, Medanta Medicity, Gurugram, Haryana, India., de Boer RA; Department of Cardiology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands., de Windt L; Department of Cardiology, Faculty of Health, Medicine and Life Sciences, School for Cardiovascular Diseases, Maastricht University, Maastricht, The Netherlands., Hamdani N; Department of Systems Physiology, Ruhr University Bochum, Bochum, Germany., Hasenfuss G; Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Hannover, Germany., Heymans S; Department of Cardiology, CARIM School for Cardiovascular Diseases Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, The Netherlands., Hulot JS; Université Paris-Descartes, Sorbonne Paris Cité, Paris, France.; Paris Cardiovascular Research Center, INSERM UMR 970, Paris, France.; Hôpital Européen Georges Pompidou, AP-HP, Paris, France., Konstam M; The CardioVascular Center of Tufts Medical Center, Boston, MA, USA., Lee RT; Department of Stem Cell and Regenerative Biology, Harvard Stem Cell Institute, Harvard University, Cambridge, MA, USA., Linke WA; Institute of Physiology II, University of Münster, Münster, Germany., Lunde IG; Institute for Experimental Medical Research, Oslo University Hospital and University of Oslo, Oslo, Norway., Lyon AR; Cardiovascular Research Centre, Royal Brompton Hospital, London, UK.; National Heart and Lung Institute, Imperial College London, London, UK., Maack C; Comprehensive Heart Failure Center, University Clinic Würzburg, Würzburg, Germany., Mann DL; Department of Medicine, Center for Cardiovascular Research, Washington University School of Medicine, St. Louis Missouri, MO, USA., Mebazaa A; Department of Anaesthesiology and Critical Care Medicine, AP-HP, Saint Louis and Lariboisière University Hospitals, Inserm U 942, Paris, France., Mentz RJ; Duke Clinical Research Institute, Durham, NC, USA., Nihoyannopoulos P; Imperial College London, NHLI, National Heart & Lung Institute, London, UK., Papp Z; Division of Clinical Physiology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Parissis J; Heart Failure Unit, Department of Cardiology, Attikon University Hospital, National and Kapodistrian University of Athens, Athens, Greece., Pedrazzini T; Experimental Cardiology Unit, Department of Cardiovascular Medicine, University of Lausanne Medical School, Lausanne, Switzerland., Rosano G; Department of Medical Sciences, IRCCS San Raffaele, Centre for Clinical and Basic Research, Pisana Rome, Italy., Rouleau J; Montreal Heart Institute and University of Montreal, Montreal, Quebec, Canada., Seferovic PM; School of Medicine, Belgrade University, Belgrade, Serbia., Shah AM; School of Cardiovascular Medicine & Sciences, British Heart Foundation Centre, King's College London, London, UK., Starling RC; Cleveland Clinic, Heart and Vascular Institute, Cleveland, OH, USA., Tocchetti CG; Department of Translational Medical Sciences, Federico II University, Naples, Italy., Trochu JN; CIC INSERM 1413, Institut du thorax, UMR INSERM 1087, University Hospital of Nantes, Nantes, France., Thum T; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hanover, Germany., Zannad F; Inserm CIC 1433, Université de Lorrain, CHU de Nancy, Nancy, France., Brutsaert DL; Antwerp University, Antwerp, Belgium., Segers VF; Laboratory of Physiopharmacology, Antwerp University, Universiteitsplein 1, Building T, Wilrijk, Antwerp, Belgium.; Division of Cardiology, Antwerp University Hospital, Edegem, Belgium., De Keulenaer GW; Laboratory of Physiopharmacology, Antwerp University, Universiteitsplein 1, Building T, Wilrijk, Antwerp, Belgium.; ZNA Hartcentrum, Antwerp, Belgium.

Publikováno v: European heart journal [Eur Heart J] 2019 Jul 01; Vol. 40 (26), pp. 2155-2163.

Neuregulin-1 attenuates stress-induced vascular senescence.

Autor: Shakeri H; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium., Gevaert AB; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.; Department of Cardiology.; Laboratory for Cellular and Molecular Cardiology, Department of Cardiology, Antwerp University Hospital (UZA), Antwerp, Belgium., Schrijvers DM; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium., De Meyer GRY; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium., De Keulenaer GW; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium., Guns PDF; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium., Lemmens K; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium., Segers VF; Laboratory of Physiopharmacology, University of Antwerp, Universiteitsplein 1, 2610 Antwerp, Belgium.; Department of Cardiology.

Publikováno v: Cardiovascular research [Cardiovasc Res] 2018 Jun 01; Vol. 114 (7), pp. 1041-1051.

Neuregulin-1 attenuates development of nephropathy in a type 1 diabetes mouse model with high cardiovascular risk.

Autor: Vandekerckhove L; Laboratory of Physiopharmacology, University of Antwerp, Wilrijk, Belgium; and., Vermeulen Z; Laboratory of Physiopharmacology, University of Antwerp, Wilrijk, Belgium; and., Liu ZZ; AG Nierengefäßphysiologie, Institut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, Berlin, Germany., Boimvaser S; Laboratory of Physiopharmacology, University of Antwerp, Wilrijk, Belgium; and., Patzak A; AG Nierengefäßphysiologie, Institut für Vegetative Physiologie, Charité-Universitätsmedizin Berlin, Berlin, Germany., Segers VF; Laboratory of Physiopharmacology, University of Antwerp, Wilrijk, Belgium; and., De Keulenaer GW; Laboratory of Physiopharmacology, University of Antwerp, Wilrijk, Belgium; and gilles.dekeulenaer@uantwerpen.be.

Publikováno v: American journal of physiology. Endocrinology and metabolism [Am J Physiol Endocrinol Metab] 2016 Apr 01; Vol. 310 (7), pp. E495-504. Date of Electronic Publication: 2016 Jan 19.

Pathophysiology of diastolic dysfunction in chronic heart failure.

Autor: Segers VF; University of Antwerp, Universiteitsplein 1, Campus Drie Eiken, Bldg T, 2nd Floor, 2610 Wilrijk, Belgium., De Keulenaer GW

Publikováno v: Future cardiology [Future Cardiol] 2013 Sep; Vol. 9 (5), pp. 711-20.